CXCR3 exerts its biological effects through engagement by three IFN-γ inducible ligands (CXCL9, CXCL10 and CXCL11) that are mainly secreted by monocytes, endothelial cells, fibroblasts and tumor cells (Figure 1). Here, CXCR3 is linked to neoplasm.